Latest news

Hidden Gems of the Swedish drug Discovery & Development Pipeline Nov 17

17 November, 2020

Nov 17, Nanologica will take part of the exclusive Swedish-US networking event Hidden Gems of the Swedish Drug Discovery & Development Pipeline. The aim of the event is to bring together a selection of Swedish and Californian companies active in this field, ranging from small highly innovative companies to big pharma and biotech. Organisers include the US Embassy in Sweden, the Swedish Embassy in the US, AmCham, SACC & BIOCOM. The Swedish and Californian drug

Presentation of Nanologica from The Spotlight Next Event, Nov 12 2020

16 November, 2020

Presentation of Nanologica from the Redeye R&D Tools Seminar Nov 10, 2020

13 November, 2020

CEO Andreas Bhagwani presents Nanologica at the Redeye R&D Tools Seminar Nov 10, 2020.

Nanologicas valberedning utsedd inför årsstämman 2021

5 November, 2020

I enlighet med beslut på årsstämman den 28 maj 2020 har styrelsens ordförande kontaktat bolagets tre röstmässigt största ägare eller ägargrupper som var och en har erbjudits att utse en representant att utgöra valberedning i Nanologica AB. De tre största aktieägarna eller ägargrupperna per den 30 september 2020 har utsett var sin representant så att valberedningen inför årsstämman 2021 består av följande tre ledamöter: Thomas Eldered (Flerie Invest AB) – ordförande Mattias Häggblom (Swedbank Robur

Nanologica presenterar på Spotlight Nexts bolagsdag den 12 november

4 November, 2020

Nanologica presenterar på Spotlight Nexts bolagsdag den 12 november kl 15.15. Följ eventet via länken nedan

Nanologica to participate at Redeye R&D Tools Seminar Nov 10

3 November, 2020

November 10 at 10.15, Nanologica will participate at Redeye R&D Tools Seminar. The event can be live streamed on redeye.se. In this seminar, Redeye invites companies that provide tools & supplies for the biopharma industry and academia. An investment in this segment can offer exposure to strong underlying trends in the pharma industry, without necessarily taking binary bets. In recent years, some of the top performers within the life science sector belong to this segment,

About us

Nanologica is a Swedish life science tools company that develops, manufactures, and sells advanced consumables to pharmaceutical manufacturers. Nanologica’s products are specially developed for the purification of peptide drugs, such as insulin and GLP-1 analogues. Due to effective purification and a long lifetime for the products, they can increase productivity and reduce costs for pharmaceutical manufacturers. Nanologica operates in a global niche market that is growing as a result of increased demand for drugs for the treatment of diabetes and obesity. The company’s mission is to increase access to cost-effective drugs through its purification products and thereby contribute to more patients around the world having access to life-saving treatments. The company is headquartered in Södertälje and Nanologica’s share (NICA) is listed for trading on Nasdaq Stockholm Main Market.

Categories

News archive